Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Soluble Tumor Necrosis Factor Receptor Type I Measurement

Known as: Soluble TNF Receptor Type I, TNFSR1 
The determination of the amount of soluble TNF receptor type I present in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery.
BACKGROUND A number of proteins secreted from adipose tissue, known as adipokines, are involved in the inflammatory process. The… Expand
  • figure 2
  • figure 1
  • table 1
  • table 2
  • table 3
Highly Cited
2009
Highly Cited
2009
Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD
IntroductionInterleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNFα) are potentially important in Chronic Obstructive… Expand
  • table I
  • figure 1
  • table II
  • figure 2
2006
2006
Effect of Inhibitor of Tumor Necrosis Factor‐α and Oxatomide on Immune Mediated Otitis Media
Objective: Inflammatory mediators (IMs) play a major role in the production of middle ear effusion (MEE). Tumor necrosis factor… Expand
2005
2005
Equivalence of the Acute Cytokine Surge and Myocardial Injury after Coronary Artery Bypass Grafting with and without a Novel Extracorporeal Circulation System
Cardiopulmonary bypass (CPB) contributes to a morbidity-inducing systemic Inflammatory response after cardiac surgery. We… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2004
Highly Cited
2004
Inflammatory Markers and Incident Mobility Limitation in the Elderly
Objectives: To examine the relationship between indicators of inflammation and the incidence of mobility limitation in older… Expand
Highly Cited
2004
Highly Cited
2004
Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia
ObjectiveTo examine whether cytokine concentrations change in the pulmonary compartment during the development of ventilator… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
2003
2003
Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of…
OBJECTIVE To study tumor necrosis factor alpha (TNFalpha) -308 gene promoter polymorphism and circulating levels of TNFalpha and… Expand
2003
2003
Effect of acute hyperglycaemia on selected plasma and urinary cytokine antagonists in Type 1 diabetes mellitus
Aims/hypothesisSeveral cytokines have been implicated in the pathogenesis of diabetic nephropathy. Their ability to generate a… Expand
  • table 1
  • table 2
2002
2002
Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I
Experimental autoimmune thyroiditis (EAT) is inducible in mice by immunization with thyroglobulin and adjuvant. Previous studies… Expand
Highly Cited
1998
Highly Cited
1998
Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis.
Serum concentrations of tumor necrosis factor-alpha (TNF), interleukin (IL)-1beta, and their circulating inhibitors soluble TNF… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE